Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Edwards Lifesciences Stock News

EWNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$71.53

0.330.46%

At close: -

$71.53

0.000.00%

After Hours: 6:01 PM EDT

Q1 2025 Earnings in 6 days from now on Wed Apr 23rd, after the market close

Conference call scheduled in 6 days at 17:00 PM Click to view the webcast

Edwards Lifesciences (EW) Forecast

News

Earnings Edwards Lifesciences (EW) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Edwards Lifesciences Stock News | NYSE:EW | Benzinga

Get the latest news on Edwards Lifesciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Edwards Lifesciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 17, 2025

Is Edwards Lifesciences Gaining or Losing Market Support?
Benzinga Insights - 12 hours ago

Monday, April 14, 2025

Edwards Lifesciences' SAPIEN M3 Mitral Valve ...
Benzinga Newsdesk - 3 days ago

Friday, April 11, 2025

Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Benzinga Insights - 6 days ago
Truist Securities Maintains Hold on Edwards L...
Benzinga Newsdesk - 6 days ago

Friday, April 04, 2025

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Vandana Singh - Apr 4, 2025, 3:47PM

Friday, March 28, 2025

Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Avi Kapoor - Mar 28, 2025, 8:37AM

Monday, March 17, 2025

How Is The Market Feeling About Edwards Lifesciences?
Benzinga Insights - Mar 17, 2025, 3:30PM

Wednesday, February 26, 2025

A Look Into Edwards Lifesciences Inc's Price Over Earnings
Benzinga Insights - Feb 26, 2025, 8:45AM

Tuesday, February 18, 2025

Peering Into Edwards Lifesciences's Recent Short Interest
Benzinga Insights - Feb 18, 2025, 3:15PM

Friday, February 14, 2025

Insider Unloading: LESLIE HEISZ STONE Sells Options, Realizes $179K
Benzinga Insights - Feb 14, 2025, 10:02AM

Thursday, February 13, 2025

Barclays Maintains Overweight on Edwards Life...
Benzinga Newsdesk - Feb 13, 2025, 10:39AM
Canaccord Genuity Maintains Hold on Edwards L...
Benzinga Newsdesk - Feb 13, 2025, 6:57AM

Wednesday, February 12, 2025

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
Vandana Singh - Feb 12, 2025, 2:51PM
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Piero Cingari - Feb 12, 2025, 1:22PM
RBC Capital Reiterates Outperform on Edwards ...
Benzinga Newsdesk - Feb 12, 2025, 11:24AM
Piper Sandler Maintains Neutral on Edwards Li...
Benzinga Newsdesk - Feb 12, 2025, 9:30AM
Evercore ISI Group Maintains In-Line on Edwar...
Benzinga Newsdesk - Feb 12, 2025, 9:10AM
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk - Feb 12, 2025, 8:28AM
Morgan Stanley Maintains Equal-Weight on Edwa...
Benzinga Newsdesk - Feb 12, 2025, 8:28AM
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk - Feb 12, 2025, 6:37AM

Tuesday, February 11, 2025

Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk - Feb 11, 2025, 4:16PM
Edwards Lifesciences Sees Q1 Adj. EPS $0.58-$...
Benzinga Newsdesk - Feb 11, 2025, 4:16PM
Edwards Lifesciences Q4 2024 Adj. EPS $0.59 B...
Benzinga Newsdesk - Feb 11, 2025, 4:15PM
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Piero Cingari - Feb 11, 2025, 1:36PM
Earnings Scheduled For February 11, 2025
Benzinga Insights - Feb 11, 2025, 3:32AM

Thursday, January 30, 2025

Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk - Jan 30, 2025, 2:46PM
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Nabaparna Bhattacharya - Jan 30, 2025, 2:21PM
11 Analysts Have This To Say About Edwards Lifesciences
Benzinga Insights - Jan 30, 2025, 2:01PM
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor - Jan 30, 2025, 6:35AM
Stifel Upgrades Edwards Lifesciences to Buy, ...
Benzinga Newsdesk - Jan 30, 2025, 4:29AM

Friday, January 24, 2025

Smart Money Is Betting Big In Edwards Lifesciences Options
Benzinga Insights - Jan 24, 2025, 2:30PM

Thursday, January 16, 2025

Wolfe Research Downgrades Edwards Lifescience...
Benzinga Newsdesk - Jan 16, 2025, 12:02PM

Monday, December 16, 2024

Assessing Edwards Lifesciences: Insights From 20 Financial Analysts
Benzinga Insights - Dec 16, 2024, 3:00PM
B of A Securities Upgrades Edwards Lifescienc...
Benzinga Newsdesk - Dec 16, 2024, 9:48AM

Wednesday, December 11, 2024

Citigroup Maintains Buy on Edwards Lifescienc...
Benzinga Newsdesk - Dec 11, 2024, 2:07PM

Thursday, December 05, 2024

Goldman Sachs Maintains Buy on Edwards Lifesc...
Benzinga Newsdesk - Dec 5, 2024, 12:34PM
Truist Securities Reiterates Hold on Edwards ...
Benzinga Newsdesk - Dec 5, 2024, 11:50AM
Stifel Maintains Hold on Edwards Lifesciences...
Benzinga Newsdesk - Dec 5, 2024, 11:06AM
RBC Capital Maintains Outperform on Edwards L...
Benzinga Newsdesk - Dec 5, 2024, 10:42AM
Canaccord Genuity Maintains Hold on Edwards L...
Benzinga Newsdesk - Dec 5, 2024, 7:30AM

Wednesday, December 04, 2024

Edwards Lifesciences Outlines Vision For Growth At Investor Conference
Vandana Singh - Dec 4, 2024, 11:40AM
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk - Dec 4, 2024, 9:37AM
Edwards Lifesciences Expects 2025 Sales Of $5...
Benzinga Newsdesk - Dec 4, 2024, 6:07AM

Monday, December 02, 2024

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh - Dec 2, 2024, 2:29PM

Wednesday, November 27, 2024

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts
Benzinga Insights - Nov 27, 2024, 1:01PM
RBC Capital Maintains Outperform on Edwards L...
Benzinga Newsdesk - Nov 27, 2024, 12:09PM

Monday, November 25, 2024

Edwards Lifesciences' SAPIEN 3 Ultra RESILIA ...
Benzinga Newsdesk - Nov 25, 2024, 3:41AM

Wednesday, October 30, 2024

Why is Boston Scientific Stock Trading Lower On Wednesday?
Vandana Singh - Oct 30, 2024, 3:08PM
Shares Of Boston Scientific See Volume; Compa...
Benzinga Newsdesk - Oct 30, 2024, 11:38AM
TRISCEND II Trial Shows Edwards EVOQUE System...
Benzinga Newsdesk - Oct 30, 2024, 11:03AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved